Plandai Biotechnology Discusses Cannabis Extract Opportunities and Research Potential

Vision is to Produce World’s Only Full-Profile Non-Psychoactive Cannabis Extract

LONDON, UNITED KINGDOM, June 14, 2018 (GLOBE NEWSWIRE) — Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company”), producer of the highly bioavailable Phytofare® catechin complex, today discussed opportunities in the cannabis space and the Company’s efforts to develop the first and only full-profile, non-psychoactive cannabis extract. 

Callum Cottrell-Duffield, Chief Operating Officer of Plandaí, released the following statement, “We are one hundred percent focused on getting a full-profile, non-psychoactive cannabis extract product to market.  We believe that with the synergies of the full cannabinoid profile, including the acid precursors of THC and CBD, the extract will yield a finished product with great consumer potential.  Prior research has demonstrated that cannabis, in its natural state, does not have psychotropic properties.  It is the process of heating and drying cannabis that metabolizes the THC-A and THC-B precursors into psychoactive THC.  Our extraction method,

... read more at: http://markets.businessinsider.com/news/stocks/plandai-biotechnology-discusses-cannabis-extract-opportunities-and-research-potential-1027004878

Leave a Reply

Your email address will not be published. Required fields are marked *